the use of durvalumab in locally advanced nsclc
Published 6 years ago • 136 plays • Length 3:07Download video MP4
Download video MP3
Similar videos
-
4:15
safety profile of durvalumab in locally advanced nsclc
-
1:28
durvalumab as a consolidation therapy for locally advanced nsclc
-
3:22
locally advanced nsclc: durvalumab and the pacific trial
-
0:58
an expert’s thoughts on the fda approval of durvalumab in locally advanced lung cancers
-
5:13
effectively managing treatment with durvalumab
-
2:52
examining recent pacific trial updates for durvalumab in locally advanced nsclc
-
25:26
locally advanced nsclc: combination therapy with targeted and immunotherapy agents
-
1:37
locally advanced nsclc: next steps in research
-
6:47
case 1: immunotherapy in locally advanced nsclc
-
5:21
locally advanced nsclc: treating with i-o
-
1:01
impact of durvalumab as consolidation therapy in nsclc
-
3:45
options for systemic therapy in locally advanced nsclc
-
1:18
a study of chemotherapy with durvalumab and tremelimumab in nsclc
-
3:57
anti–pd-l1 therapy for locally advanced nsclc
-
6:50
implications for using durvalumab in stage 3 nsclc
-
5:15
case 1: surgery and chemotherapy in locally advanced nsclc
-
2:26
durvalumab following chemoradiotherapy and surgery
-
1:38
practical considerations for durvalumab in stage 3 nsclc
-
4:25
durvalumab tolerability in non–small cell lung cancer